Review and Update on mRNA Vaccines
Center for Health Policy
October 17, 2021
As the data comes in, we can now assess the new generation of vaccines (mRNA) compared to naturally acquired immunity and previous vaccines made from weakened or "attenuated" viruses.
As it turns out, the oft-repeated statement that "we know the vaccines are safe and effective" is not wholly accurate. They are increasingly being shown to be only transiently and partially effective.
Its clear vaccines have saved many lives, but not all.
Unfortunately, but predictably, the mRNA vaccine's protection is short-lived.
The vaccinated people frequently carry other strains in their nostrils without getting sick, notably the dominant Delta variant. This allows the vaccine time to mutate. Therefore, we have a less deadly but more contagious variant, Delta. In other words, the vaccine actually allowed and encouraged the emergence of the Delta variant; this is according to Dr. Robert Malone, a prominent virologist, and inventor of the mRNA vaccine.
The problem is the delay in achieving herd immunity.
According to a recent Israeli study conducted by healthcare experts, including the Maccabi Healthcare Services, confirms that immunity to SARS-Cov-2 (COVID-19) and all of its variants are more broad, more effective, and more long-lasting (if not permanent) if you have survived the actual infection as opposed to the transient immunity induced by the vaccine. There is no ambiguity in the data; natural immunity is more effective than a vaccine and likely will be permanent.
Moving on to vaccine mandates.
As it is now evident in the Israeli study that the best, broadest, and most permanent immunity is natural immunity from having had the virus, a very good choice for the unvaccinated is to remain so. To acquire a better, broader, and more permanent immunity against virtually all strains of COVID-19, the better option is natural immunity, not vaccines in perpetuity.
If enough people get the milder Delta variant, we will achieve herd immunity from it in the unvaccinated population. Unfortunately, the repeatedly vaccinated population will continue to produce mutant escape viruses, which will torment that population and may produce, although unlikely, another highly lethal variant. This is far less ideal than herd immunity. From a traditional infectious disease perspective, this is like taking a few penicillin pills instead of the full ten days, which produces penicillin-resistant strains.
Finally, there is thought to be an excellent future for mRNA technology, especially for cancer chemotherapy, but this COVID-19 vaccine experience should give us pause. We should now concentrate on therapeutic treatment of the COVID-19 disease early on when it is treatable.
For a complete bibliography of this topic, you can read more here: